51 results
Page 2 of 3
POSASR
wfr 42uz9h65mq
28 Feb 22
Automatic shelf registration (post-effective amendment)
4:16pm
S-3ASR
EX-1.2
wiazbu7gbbrhf izmhc
2 Apr 21
Automatic shelf registration
4:59pm
S-3ASR
0rn3us smpjq3ht04
2 Apr 21
Automatic shelf registration
4:59pm
8-K
EX-1.1
0vheh 2hgy
9 Dec 20
Entry into a Material Definitive Agreement
4:38pm
424B5
k8d4 br407cdk
9 Dec 20
Prospectus supplement for primary offering
4:02pm
424B5
rf2kg80z64l6sid0f
7 Dec 20
Prospectus supplement for primary offering
4:10pm
8-K
EX-99.2
pz8pm7dixvfp0 4yx
4 Dec 20
Sutro Biopharma Announces Encouraging Interim Data on STRO-002 Phase 1 Dose-Escalation Study for Patients with Ovarian Cancer
12:00am
8-K
EX-99.1
qzvpzt 68d6
4 Dec 20
Sutro Biopharma Announces Encouraging Interim Data on STRO-002 Phase 1 Dose-Escalation Study for Patients with Ovarian Cancer
12:00am
8-K
EX-1.1
ghm1gnsy nfv8
12 May 20
Entry into a Material Definitive Agreement
5:14pm
424B5
5p5fe
12 May 20
Prospectus supplement for primary offering
5:02pm
424B5
6jhiqzyr5ntp gt
11 May 20
Prospectus supplement for primary offering
4:12pm